Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
InflaRx Shares Plunge After Disappointing Results On Vilobelimab In Critically Ill COVID-19 Patients
March 31, 2022
Tickers
IFRX
From Benzinga
Omicron More Severe For Unvaccinated Children Than Other Strains, Hong Kong Study Finds: Bloomberg
March 31, 2022
From Benzinga
From Benzinga
From Benzinga
Adagio's COVID-19 Antibody Meets Primary Goals Across Pre & Post-Exposure Prophylaxis, Treatment
March 30, 2022
Tickers
ADGI
From Benzinga
Omicron BA.2 Variant Represents More Than 50% COVID-19 Cases, Says CDC Estimates: WSJ
March 30, 2022
From Benzinga
Can Antiretroviral Treatment With Protease Inhibitor In HIV Patients Lower COVID-19 Risk?
March 29, 2022
Tickers
PFE
From Benzinga
FDA Authorizes Fourth Dose Of Moderna, Pfizer/BioNTech COVID-19 Vaccines For Older People
March 29, 2022
From Benzinga
From Benzinga
Pfizer's COVID-19 Oral Therapy To Be Tested In Hospitalized COVID-19 Patients In UK: Reuters
March 28, 2022
Tickers
PFE
From Benzinga
FDA Says Current Dose Of GSK-Vir's COVID-19 Therapy Unlikely To Work Against Omicron Subvariant
March 28, 2022
From Benzinga
Pfizer, Moderna and J&J Face Shareholder Pressure To Make COVID-19 Shots More Available To Poorer Countries: WSJ
March 28, 2022
From Benzinga
From Benzinga
From Benzinga
Biden Administration Contemplating Second COVID-19 Booster Shot Recommendation Within Weeks: Politico
March 23, 2022
From Benzinga
From Benzinga
From Benzinga
Novavax's COVID-19 Vaccine Scores Green Light In India with First Approval For Adolescents
March 23, 2022
Tickers
NVAX
From Benzinga
Windtree Posts Mid-Stage Study Data On Lucinactant For COVID-19-Associated Respiratory Distress
March 22, 2022
Tickers
WINT
From Benzinga
From Benzinga
Twist Bioscience Launches Synthetic RNA Positive Controls For SARS-CoV-2 Encapsulated Minicapsules
March 21, 2022
Tickers
TWST
From Benzinga
Sorrento's Chimeric mRNA COVID-19 Vaccine Candidate Shows Preclinical Action Against Omicron Variants
March 21, 2022
Tickers
SRNE
From Benzinga
Health Experts Forecast Increase In COVID-19 Cases In US Amid New Omicron Subvariant: CNBC
March 21, 2022
From Benzinga
From Benzinga
Maker Of Pfizer's COVID-19 Vaccine mRNA-Delivery Tech Sues Arbutus Biopharma: Reuters
March 18, 2022
From Benzinga
Like Pfizer, Moderna Seeks FDA Approval For Fourth COVID-19 Shot Or Second Booster Dose
March 18, 2022
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
